Stock REVB REVELATION BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Revelation Biosciences, Inc.

Equities

REVB

US76135L5075

Delayed Nasdaq
Other stock markets
 10:06:43 2024-07-03 am EDT 		5-day change 1st Jan Change
1.76 USD -1.65% Intraday chart for Revelation Biosciences, Inc. -11.56% -88.28%
Jun. 24 Revelation Biosciences Shares Jump on Positive Results for Investigational Drug Gemini MT
Jun. 24 Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker Activity CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker Activity
CI
Revelation Biosciences Inc. Announces Appointment of Lakhmir Chawla to Board of Directors
CI
Revelation Biosciences Inc. Appoints Dr. Julia Bohannon and Dr. Antonio Hernandez to Scientific Advisory Board
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. REVB Stock
  4. News Revelation Biosciences, Inc.
  5. Insiders